1-5 of 5
Anish Thomas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P047: A phase 1/2 trial of CBX-12, an alphalexTM peptide drug conjugate, in patients with advanced or metastatic refractory solid tumors

Anthony Tolcher, Joseph Paul Eder, David Sommerhalder, Sophia Gayle, Paul Pearson, Deb Chapman, Arthur P. DeCillis, Anish Thomas, Funda Meric-Bernstam
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P047.
DOI: https://doi.org/10.1158/1535-7163.TARG-21-P047
Published: 01 December 2021
View article
Journal Articles

Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents

Ukhyun Jo, Ilya S. Senatorov, Astrid Zimmermann, Liton Kumar Saha, Yasuhisa Murai, Se Hyun Kim, Vinodh N. Rajapakse, Fathi Elloumi, Nobuyuki Takahashi, Christopher W. Schultz, Anish Thomas, Frank T. Zenke, Yves Pommier
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (8): 1431–1441.
DOI: https://doi.org/10.1158/1535-7163.MCT-20-1026
Published: 01 August 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract A048: Whole exome sequencing of circulating free DNA reveals concordance with matched metastatic tumors and predicts survival in small cell lung cancer patients

Vinodh N. Rajapakse, Nobuyuki Takahashi, Lorinc Pongor, Sehyun Kim, Anish Thomas
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): A048.
DOI: https://doi.org/10.1158/1535-7163.TARG-19-A048
Published: 01 December 2019
View article
Journal Articles

Abstract CN05-03: Precision therapeutics with DNA-damaging agents

Yves G. Pommier, William C. Reinhold, Junko Murai, Anish Thomas
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): CN05-03.
DOI: https://doi.org/10.1158/1535-7163.TARG-17-CN05-03
Published: 01 January 2018
View article
Journal Articles

Abstract A095: Phase Ib study of anetumab ravtansine in combination with pemetrexed and cisplatin in patients with mesothelin-expressing epithelial mesothelioma or nonsquamous non-small cell lung cancer

Raffit Hassan, Ding Wang, John Wrangle, Anish Thomas, Angus Byars, Lianne Asschert, Rolando Atienza, Prabhu Rajagopalan, Annette Walter, Jun Zhang, Nenad Sarapa, Hedy Kindler
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): A095.
DOI: https://doi.org/10.1158/1535-7163.TARG-17-A095
Published: 01 January 2018
View article